There are 2949 resources available
LBA10 - Critical role of eosinophils during response to immune checkpoint blockade in breast cancer and other cancer types
Presenter: Leonie Voorwerk
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
88MO - T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer
Presenter: Marcus Schmidt
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1931MO - A HER3/DUSP6 loop determines sensitivity to HER2-targeted therapies in breast cancer
Presenter: Majid Momeny
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1932MO - Ki67 expression and CDK4/6i activity: An emerging role for PIK3CA mutations in metastatic breast cancer patients
Presenter: Marzia Del Re
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1933MO - TransFAL: Establishment of clinical trial-matched luminal breast cancer patient-derived xenografts (PDX) for translational studies
Presenter: Marta Palafox
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1077MO - PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study
Presenter: Julie Delyon
Session: Mini Oral - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1078MO - MIND-DC: A randomized phase III trial to assess the efficacy of adjuvant dendritic cell vaccination in comparison to placebo in stage IIIB and IIIC melanoma patients
Presenter: Kalijn Bol
Session: Mini Oral - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1161MO - Lanreotide autogel (LAN) and temozolomide (TMZ) combination therapy in progressive thoracic neuroendocrine tumours (TNETs): ATLANT study results
Presenter: Piero Ferolla
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1162MO - Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results
Presenter: Marianne Pavel
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
LBA85 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Presenter: Benjamin Besse
Session: Mini Oral - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast